Trial intelligence / Profile preview

Effect of age on the minimum intrathecal bupivacaine dose for motor block

ChiCTR-TNRC-11001383Phase 4Completed

Sponsor
The First College of Clinical Medical Science, China Three Gorges University
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of bupivacaine (2 cohorts), sponsored by The First College of Clinical Medical Science, China Three Gorges University. Primary endpoint: Bromage scale. Started May 2010; status: completed.

02

Drugs

bupivacaine

Beyond the preview

Go deeper on ChiCTR-TNRC-11001383.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TNRC-11001383.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call